Cite
Prediction of early clinical response to neoadjuvant chemotherapy in Triple-negative breast cancer: Incorporating Radiomics through breast MRI.
MLA
Lee, Hyo-Jae, et al. “Prediction of Early Clinical Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: Incorporating Radiomics through Breast MRI.” Scientific Reports, vol. 14, no. 1, Sept. 2024, p. 21691. EBSCOhost, https://doi.org/10.1038/s41598-024-72581-y.
APA
Lee, H.-J., Lee, J. H., Lee, J. E., Na, Y. M., Park, M. H., Lee, J. S., & Lim, H. S. (2024). Prediction of early clinical response to neoadjuvant chemotherapy in Triple-negative breast cancer: Incorporating Radiomics through breast MRI. Scientific Reports, 14(1), 21691. https://doi.org/10.1038/s41598-024-72581-y
Chicago
Lee, Hyo-Jae, Jeong Hoon Lee, Jong Eun Lee, Yong Min Na, Min Ho Park, Ji Shin Lee, and Hyo Soon Lim. 2024. “Prediction of Early Clinical Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: Incorporating Radiomics through Breast MRI.” Scientific Reports 14 (1): 21691. doi:10.1038/s41598-024-72581-y.